KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd has announced that Rinani Group Bhd has emerged as a substantial shareholder in the group with a 5.85% stake.
“We are excited to have Rinani Group on board as a substantial shareholder. Their investment comes at a pivotal time as we are transitioning towards biopharmaceuticals and pursuing various growth initiatives,” group executive chairman Azri Azerai said in a statement.
Azri emphasised that the addition of Rinani as a substantial shareholder would play a crucial role in the group's restructuring and next phase of growth.
"Their involvement brings a wealth of opportunities in life sciences and its applications, which aligns with our growth strategy," he said.
